LBBW Aktienanleihe MRK 24.05.2024/ DE000LB38HD9 /
2024-05-15 9:46:23 AM | Chg.-0.010 | Bid1:02:14 PM | Ask1:02:14 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
99.730EUR | -0.01% | 99.730 Bid Size: 250,000 |
- Ask Size: - |
MERCK KGAA O.N. | 125.93 - | 2024-05-24 | Call |
GlobeNewswire
2:30 PM
Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Cl...
GlobeNewswire
2:05 PM
Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
2:00 PM
PDS Biotech Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA